PhD candidate ‘Improving recognition of patients with PHTS’
3 years As a PhD candidate ‘Improving recognition of patients with PHTS’, you will work on easy-to-apply sets of clinical criteria that can be assessed by each healthcare provider who diagnoses a common feature of PHTS.
PTEN Hamartoma Tumor Syndrome (PHTS) is a rare genetic predisposition that results in a broad spectrum of diseases and is caused by a germline pathogenic variant in the PTEN gene. PHTS patients have a strong increased risk for several types of cancer and can present with various benign neoplasia, skin lesions, macrocephaly and developmental delay.
Currently, many people with PHTS are recognised as such. This means that many PHTS patients do not receive the surveillance and treatment they need, and patients may develop conditions that possible could have been prevented or be diagnosed at an earlier stage. Most of the disease characteristics of PHTS are on their own common in the general population which hampers recognition of these rare PHTS patients. In addition, each disease expression of PHTS is diagnosed by different health care disciplines and at different ages, such as skin lesions (dermatologist), vascular malformation (radiologist), developmental delay (neurology), an enlarged thyroid (endocrinologist) or breast cancer (oncologist/surgeon).
In a large cohort of PHTS patients and PTEN-negative control patients extended clinical characteristics will be collected and assessed. The best performing clinical criteria will be assessed for further implementation. The PhD candidate is supervised by Prof. Nicoline Hoogerbrugge (medical specialist and professor in Hereditary Cancer) and Dr. Janet Vos (postdoc and epidemiologist).
This PhD project (PIPGEN - PhD Project 3) is part of the PIPgen project (“PIPgen - PI3K/PTEN-related monogenic disease to understand cancer"), an Innovative Training Network funded by the European Union’s Horizon 2020 offering 15 PhD fellowships to train Early Stage Researchers in the field of PI3K/PTEN related diseases.
The PIPgen project network offers a very competitive 3-year full-time contract in one of the 11 world-leading European institutions from the network. Selected candidates will carry out secondments in other European institutions within the network to achieve research and training excellence, and to improve their future career perspectives both in academia and in the private sector.
Tasks and responsibilities
Setting up and conducting scientific research within the field of hereditary cancer and epidemiology.
Implementation and coordination of data collection in a local and European context, such as clinical data, questionnaire research and national registries.
Data analysis of clinical data and questionnaire data.
Presenting research results during internal and external meetings and (international) conferences.
Writing scientific publications.
Possibility to follow courses to (further) develop relevant skills.
Possibility to (co-) supervise bachelor or master students during their scientific internship.
Working in a multidisciplinary team including researchers, epidemiologists, biologists, molecular geneticists, clinical geneticists, psychologists, radiologists and gynecologists.
Working and collaborating within an international project.
Complete the project with a dissertation.
Working at Radboud university medical center means that you are ahead of the curve and working together on the healthcare of the future. But there is more. Our secondary terms of employment are impressive. These are fully tailored to you thanks to our Employment Conditions Selection Model. At Radboud university medical center, you will be given trust, and you will take the responsibility to handle everything together. We provide annual courses, both professional and personal.
In addition to your monthly salary and an annual vacation allowance of 8%, you will receive an end-of-year bonus of 8.3%.
If you work irregular hours, you will receive an allowance.
As a full-time employee (36 hours per week), you are entitled to approximately 168 vacation hours (over 23 days) per year.
Radboud university medical center pays 70% of the pension premium. You pay the rest of the premium with your gross salary.
You get a discount on health insurance as well: you can take advantage of two group health insurance plans. UMC Zorgverzekering and CZ collectief.
You are available at short notice. The PIPgen project fellowships start between September 2021 and February 2022. The start date of this project is negotiable, but is preferably in September or October 2021.
In addition to our terms of employment, we also offer employees various other attractive facilities, such as childcare and sports facilities. Want to learn more? Take a look at the Cao UMC. The department of Human Genetics has >350 employees, distributed over three divisions: Clinical Genetic, Genome Diagnostics, and Genome Research. The department has ample experience in clinical cancer genetics, from recognition to diagnostic germline testing, phenotyping, genotyping, treatment and surveillance of patients.
Within the department, a broad spectrum of research is carried out into hereditary cancer: 'from molecule to man to population', in which there is close collaboration between the various disciplines. This PhD project operates in the spectrum: 'man to population'.
At the moment there are more than 1,300 PhD candidates at our medical hospital. This number includes PhD candidates on our pay roll as well as external candidates (those employed somewhere else but researching on our premises).
Radboud Institute for Health Sciences: ± 700
Radboud Institute for Molecular Life Sciences: ± 400
Donders Center for Medical Neurosciences: ± 200
Read what it is like to do a PhD at the Radboud University Medical Center.
Radboud university medical center is a university medical center for patient care, scientific research, and education in Nijmegen. Radboud university medical center strives to be at the forefront of shaping the healthcare of the future. We do this in a person-centered and innovative way, and in close collaboration with our network. We want to have a significant impact on healthcare. We want to improve with each passing day, continuously working towards better healthcare, research, and education. And gaining a better understanding of how diseases arise and how we can prevent, treat, and cure them, day in and day out. This way, every patient always receives the best healthcare, now and in the future. Because that is why we do what we do.
Read more about our strategy and what working at Radboud university medical center means. Our colleagues would be happy to tell you about it. #weareradboudumc. You are a dynamic and enthusiastic PhD candidate who works accurately and in a structured way. You have good communication skills, both in Dutch and English. You can work independently as well as collaborate in a multidisciplinary team within a European context.
You can understand written Dutch.
You have completed a master's degree in Biomedical Sciences, Epidemiology, Medicine or in a similar field.
You have affinity with epidemiological research and an interest in epidemiology and hereditary cancer syndromes.
Experience with research, data collection and data management is preferred.
Experience with data analysis (in particular R) is a preferred.
You may not have resided or carried out their main activity (work, studies, etc.) in the Netherlands for more than 12 months in the last three years.
You are an early-stage researchers (ESR), i.e. at the date of recruitment (ITN), in the first four years (full-time equivalent research experience) of your research career and have not been awarded a doctoral degree.
All additional information about the vacancy can be obtained from Dr. Janet Vos, postdoctoral researcher Human Genetics. We would like to receive your application before 30 September 2021 via the PIPgen website, https://pipgen.eu/ . Do NOT use the 'apply now' button.